Pharmacotherapy and pregnancy: Highlights from the second international conference for individualized pharmacotherapy in pregnancy

David M. Haas, Mary F. Hebert, Offie P. Soldin, David A. Flockhart, Parvaz Madadi, James J. Nocon, Christina D. Chambers, Gary Hankins, Shannon Clark, Katherine L. Wisner, Lang Li, Jamie L. Renbarger, Lee A. Learman

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

To address provider struggles to provide evidence-based, rational drug therapy to pregnant women, a second conference was convened to highlight the current research in the field. Speakers from academic centers and institutions spoke about: the unique physiology and pathology of pregnancy; pharmacokinetic changes in pregnancy; thyroid disorders in pregnancy; pharmacogenetics in pregnancy; the role of CYP2D6 in pregnancy; treating addiction in pregnancy; the power of teratology networks to inform clinical decisions; the use of anti-depressants in pregnancy; and how to utilize computer-based modeling to aid with individualized pharmacotherapy in pregnancy. The Conference highlighted several areas of collaboration with the current Obstetrics Pharmacology Research Units Network (OPRU) and hoped to stimulate further collaboration and knowledge in the area with the common goal to improve the ability to safely and effectively use individualized pharmacotherapy in pregnancy.

Original languageEnglish (US)
Pages (from-to)439-443
Number of pages5
JournalClinical and Translational Science
Volume2
Issue number6
DOIs
StatePublished - Dec 2009

Fingerprint

Drug therapy
Drug Therapy
Pregnancy
Obstetrics
Cytochrome P-450 CYP2D6
Pharmacokinetics
Physiology
Pathology
Teratology
Pharmacogenetics
Research
Pregnant Women
Thyroid Gland
Pharmacology

Keywords

  • Pharmacogenomic
  • Pharmacology
  • Pregnancy

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Pharmacotherapy and pregnancy : Highlights from the second international conference for individualized pharmacotherapy in pregnancy. / Haas, David M.; Hebert, Mary F.; Soldin, Offie P.; Flockhart, David A.; Madadi, Parvaz; Nocon, James J.; Chambers, Christina D.; Hankins, Gary; Clark, Shannon; Wisner, Katherine L.; Li, Lang; Renbarger, Jamie L.; Learman, Lee A.

In: Clinical and Translational Science, Vol. 2, No. 6, 12.2009, p. 439-443.

Research output: Contribution to journalArticle

Haas, DM, Hebert, MF, Soldin, OP, Flockhart, DA, Madadi, P, Nocon, JJ, Chambers, CD, Hankins, G, Clark, S, Wisner, KL, Li, L, Renbarger, JL & Learman, LA 2009, 'Pharmacotherapy and pregnancy: Highlights from the second international conference for individualized pharmacotherapy in pregnancy', Clinical and Translational Science, vol. 2, no. 6, pp. 439-443. https://doi.org/10.1111/j.1752-8062.2009.00166.x
Haas, David M. ; Hebert, Mary F. ; Soldin, Offie P. ; Flockhart, David A. ; Madadi, Parvaz ; Nocon, James J. ; Chambers, Christina D. ; Hankins, Gary ; Clark, Shannon ; Wisner, Katherine L. ; Li, Lang ; Renbarger, Jamie L. ; Learman, Lee A. / Pharmacotherapy and pregnancy : Highlights from the second international conference for individualized pharmacotherapy in pregnancy. In: Clinical and Translational Science. 2009 ; Vol. 2, No. 6. pp. 439-443.
@article{b85a6269ab31429f890c32dbf3c8587d,
title = "Pharmacotherapy and pregnancy: Highlights from the second international conference for individualized pharmacotherapy in pregnancy",
abstract = "To address provider struggles to provide evidence-based, rational drug therapy to pregnant women, a second conference was convened to highlight the current research in the field. Speakers from academic centers and institutions spoke about: the unique physiology and pathology of pregnancy; pharmacokinetic changes in pregnancy; thyroid disorders in pregnancy; pharmacogenetics in pregnancy; the role of CYP2D6 in pregnancy; treating addiction in pregnancy; the power of teratology networks to inform clinical decisions; the use of anti-depressants in pregnancy; and how to utilize computer-based modeling to aid with individualized pharmacotherapy in pregnancy. The Conference highlighted several areas of collaboration with the current Obstetrics Pharmacology Research Units Network (OPRU) and hoped to stimulate further collaboration and knowledge in the area with the common goal to improve the ability to safely and effectively use individualized pharmacotherapy in pregnancy.",
keywords = "Pharmacogenomic, Pharmacology, Pregnancy",
author = "Haas, {David M.} and Hebert, {Mary F.} and Soldin, {Offie P.} and Flockhart, {David A.} and Parvaz Madadi and Nocon, {James J.} and Chambers, {Christina D.} and Gary Hankins and Shannon Clark and Wisner, {Katherine L.} and Lang Li and Renbarger, {Jamie L.} and Learman, {Lee A.}",
year = "2009",
month = "12",
doi = "10.1111/j.1752-8062.2009.00166.x",
language = "English (US)",
volume = "2",
pages = "439--443",
journal = "Clinical and Translational Science",
issn = "1752-8054",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Pharmacotherapy and pregnancy

T2 - Highlights from the second international conference for individualized pharmacotherapy in pregnancy

AU - Haas, David M.

AU - Hebert, Mary F.

AU - Soldin, Offie P.

AU - Flockhart, David A.

AU - Madadi, Parvaz

AU - Nocon, James J.

AU - Chambers, Christina D.

AU - Hankins, Gary

AU - Clark, Shannon

AU - Wisner, Katherine L.

AU - Li, Lang

AU - Renbarger, Jamie L.

AU - Learman, Lee A.

PY - 2009/12

Y1 - 2009/12

N2 - To address provider struggles to provide evidence-based, rational drug therapy to pregnant women, a second conference was convened to highlight the current research in the field. Speakers from academic centers and institutions spoke about: the unique physiology and pathology of pregnancy; pharmacokinetic changes in pregnancy; thyroid disorders in pregnancy; pharmacogenetics in pregnancy; the role of CYP2D6 in pregnancy; treating addiction in pregnancy; the power of teratology networks to inform clinical decisions; the use of anti-depressants in pregnancy; and how to utilize computer-based modeling to aid with individualized pharmacotherapy in pregnancy. The Conference highlighted several areas of collaboration with the current Obstetrics Pharmacology Research Units Network (OPRU) and hoped to stimulate further collaboration and knowledge in the area with the common goal to improve the ability to safely and effectively use individualized pharmacotherapy in pregnancy.

AB - To address provider struggles to provide evidence-based, rational drug therapy to pregnant women, a second conference was convened to highlight the current research in the field. Speakers from academic centers and institutions spoke about: the unique physiology and pathology of pregnancy; pharmacokinetic changes in pregnancy; thyroid disorders in pregnancy; pharmacogenetics in pregnancy; the role of CYP2D6 in pregnancy; treating addiction in pregnancy; the power of teratology networks to inform clinical decisions; the use of anti-depressants in pregnancy; and how to utilize computer-based modeling to aid with individualized pharmacotherapy in pregnancy. The Conference highlighted several areas of collaboration with the current Obstetrics Pharmacology Research Units Network (OPRU) and hoped to stimulate further collaboration and knowledge in the area with the common goal to improve the ability to safely and effectively use individualized pharmacotherapy in pregnancy.

KW - Pharmacogenomic

KW - Pharmacology

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=77953428242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953428242&partnerID=8YFLogxK

U2 - 10.1111/j.1752-8062.2009.00166.x

DO - 10.1111/j.1752-8062.2009.00166.x

M3 - Article

C2 - 20443937

AN - SCOPUS:77953428242

VL - 2

SP - 439

EP - 443

JO - Clinical and Translational Science

JF - Clinical and Translational Science

SN - 1752-8054

IS - 6

ER -